Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/12/2002WO2002098424A1 Novel anti-infectives
12/12/2002WO2002098423A1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/12/2002WO2002098422A1 Use of methylnaltrexone to treat immune suppression
12/12/2002WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002WO2002098419A1 Integrin linked kinase modulation of macrophage activation
12/12/2002WO2002098418A1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
12/12/2002WO2002098417A1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
12/12/2002WO2002098416A2 Antineoplastic combinations
12/12/2002WO2002098415A1 Medicine for treating obesity
12/12/2002WO2002098414A1 Methods using ptpase inhibitors and insulin
12/12/2002WO2002098413A2 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
12/12/2002WO2002098411A1 Stabilizers of antioxidants and stabilizer-added antioxidant formulations and products
12/12/2002WO2002098410A1 Combination of a ptpase inhibitor and a sulfonylurea agent
12/12/2002WO2002098409A1 Combination therapy for type ii diabetes or syndrome x
12/12/2002WO2002098408A1 Ptpase inhibitors for improving cardiovascular risk profile
12/12/2002WO2002098407A1 COMBINATION OF A PTPase INHIBITOR AND AN ALPHA-GLUCOSIDASE INHIBITOR
12/12/2002WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002WO2002098405A1 Liver fibrosis inhibitors
12/12/2002WO2002098404A1 Topical compositions for veterinary uses
12/12/2002WO2002098403A1 Steroid hormone and non-steroidal anti-inflammatory drug combinations for inducing tumor cell apoptosis
12/12/2002WO2002098402A1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
12/12/2002WO2002098401A1 Medicinal composition containing mucin
12/12/2002WO2002098400A1 Novel arylaminopropane analogues and their use for the treatment of glaucoma
12/12/2002WO2002098399A2 Cancer treatment method and compositions comprising compounds of the ginger family
12/12/2002WO2002098398A1 Methods for preventing and treating diseases and conditions associated with cellular stress
12/12/2002WO2002098397A2 Therapeutic compositions for modulating the immune response in a mammal and use thereof
12/12/2002WO2002098392A1 Nsaid formulation comprising a granular composition and an extra-granular composition
12/12/2002WO2002098391A2 Process for preparing granular compositions
12/12/2002WO2002098390A2 Delivery of aerosols containing small particles through an inhalation route
12/12/2002WO2002098389A1 Method of forming an aerosol for inhalation delivery
12/12/2002WO2002098384A1 Cosmetic and/or pharmaceutical preparations containing an extract from pterocarpus marsupium
12/12/2002WO2002098380A1 Preparation for the removal of abnormal keratin material
12/12/2002WO2002098376A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enyzmes
12/12/2002WO2002098367A2 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
12/12/2002WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002WO2002098362A2 Use of rank antagonists to treat cancer
12/12/2002WO2002098356A2 Ppp2cs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098354A2 Compositions and methods for inhibiting bone resorption
12/12/2002WO2002098353A2 Compositions and methods for inhibiting bone resorption
12/12/2002WO2002098352A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
12/12/2002WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002WO2002098347A2 Methods and compositions that affect melanogenesis (pfi-016cip/pct)
12/12/2002WO2002098345A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002WO2002098339A2 Zinc containing compositions for anti-viral use
12/12/2002WO2002098307A1 A device for the delivery of a drug to a fractured bone
12/12/2002WO2002098242A1 Calorically dense liquid oral supplement
12/12/2002WO2002098226A1 Method for reducing muscle fatigue through administration of adenosine triphosphate
12/12/2002WO2002098222A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
12/12/2002WO2002090313A8 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
12/12/2002WO2002089848A3 Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
12/12/2002WO2002089805A3 Use of regularly scheduled high dose intravenous methotrexate therapy
12/12/2002WO2002089788A3 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
12/12/2002WO2002087600A8 Use of phyllanthus constituents for treating or preventing infections caused by hepatit
12/12/2002WO2002087595A8 Treating retinal or photoreceptor degenerative diseases
12/12/2002WO2002083891A3 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
12/12/2002WO2002082044A3 Method of imaging cell death in vivo
12/12/2002WO2002081751A3 A method of increasing endogenous leptin production
12/12/2002WO2002081398A3 Additives for building industry obtained from by-products and process for their production
12/12/2002WO2002080890A3 A jasmonate pharmaceutical composition for treatment of cancer
12/12/2002WO2002076982A3 Non-nucleoside reverse transcriptase inhibitors
12/12/2002WO2002076977A3 Rho-kinase inhibitors
12/12/2002WO2002076976A3 Rho-kinase inhibitors
12/12/2002WO2002076494A3 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
12/12/2002WO2002076432A3 Pharmaceutical composition comprising a poorly water-soluble active ingredient, a surfactant and a water-soluble polymer
12/12/2002WO2002076234A3 Increasing phosphorus uptake from the gut of dairy cows by supplementing with 1-alpha-hydroxylated vitamin d
12/12/2002WO2002074798A3 The genome of a bifidobacterium
12/12/2002WO2002074756A3 Urokinase inhibitors
12/12/2002WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002WO2002072078A3 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002069946A3 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
12/12/2002WO2002068930A3 Methods and reagents to acquire mri signals and images
12/12/2002WO2002068389A3 Indole derivatives with inhibitor effects on phenol oxidase
12/12/2002WO2002068015A9 Modular infusion device and method
12/12/2002WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002WO2002065989A3 Aminoglycoside treatment for lysosomal storage diseases
12/12/2002WO2002064591A3 Carboline derivatives
12/12/2002WO2002064552A8 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
12/12/2002WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002WO2002064093A3 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/12/2002WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002WO2002060533A3 Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
12/12/2002WO2002058586A3 Systemic formulations containing beta-carotene and derivatives thereof
12/12/2002WO2002057252A3 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/12/2002WO2002056870A3 Method for treating sleep disorders
12/12/2002WO2002056869A3 Method for treating sexual disorders
12/12/2002WO2002056868A3 Method for treating stress or tension
12/12/2002WO2002056852A9 Cosmetics
12/12/2002WO2002053169A3 Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration
12/12/2002WO2002045742A3 Lipoteichoic acid immunogenic compositions and methods of making and using thereof
12/12/2002WO2002045686A3 Pharmaceutical paste comprising an acid-labile active ingredient
12/12/2002WO2002036163A3 Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
12/12/2002WO2002033090A3 Pharmaceutical preparations and methods for inhibiting tumors
12/12/2002WO2002032898A3 Novel anticholinergics, method for the production thereof and use thereof as medicaments
12/12/2002WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002WO2002028366A3 Devices and methods for management of inflammation
12/12/2002WO2002018593A3 Modulation of fas and fasl expression
12/12/2002WO2002013843A3 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
12/12/2002WO2002011709A3 Pharmaceutical, effervescent formulation containing ramipril
1 ... 5621 5622 5623 5624 5625 5626 5627 5628 5629 5630 5631 5632 5633 5634 5635 5636 5637 5638 5639 5640 5641 ... 7860